Lívia Bitencourt Pascoal

7PUBLICATIONS
23CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityCancer diagnosisHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 20, 2026
BCG Vaccination Modulates Long-Term TNF-α and sCD40L in COVID-19: An Exploratory Longitudinal Study.

|Jul 12, 2025
Resolvin D2 and Its Effects on the Intestinal Mucosa of Crohn's Disease Patients: A Promising Immune Modulation Therapeutic Target.

Livia Bitencourt Pascoal, Bruno Lima Rodrigues, Guilherme Augusto da Silva Nogueira

|Apr 28, 2025
Viral infections and immune modulation in bladder cancer: implications for immunotherapy.

Lívia Bitencourt Pascoal, Mehrsa Jalalizadeh, Gabriela Barbosa

|Feb 17, 2025
Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients.

Livia Moreira Genaro, Juliana Carron, Marina Moreira de Castro

|Feb 21, 2022
Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation.

Bruno Lima Rodrigues, Isabella Dotti, Lívia Bitencourt Pascoal

|Oct 03, 2019
Authors' Reply - Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal

Pageof 2

Frequent Collaborators

5 joint publications

Raquel Franco Leal

2 joint publications

Guilherme Nogueira

2 joint publications

Leonardo O Reis

2 joint publications

Gabriela Barbosa